Patients with atrial fibrillation (AFib) may be able to reduce their risk of developing dementia by taking direct-acting oral anticoagulants (DOACs) instead of warfarin, according to a new study published in the Journal of the American Heart Association.[1] The study’s authors tracked data from...
Reduces not eliminates but hopeful